Esperion Therapeutics
ESPR
#7490
Rank
โ‚น28.53 B
Marketcap
โ‚น144.22
Share price
5.70%
Change (1 day)
-16.50%
Change (1 year)

Revenue for Esperion Therapeutics (ESPR)

Revenue in 2024 (TTM): โ‚น27.89 Billion

According to Esperion Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น28.69 Billion. an increase over the revenue in the year 2023 that were of โ‚น9.68 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Esperion Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น28.50 B194.36%
2023 โ‚น9.68 B55.06%
2022 โ‚น6.24 B6.96%
2021 โ‚น5.83 B-64.91%
2020 โ‚น16.64 B57.29%
2019 โ‚น10.57 B
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2000 โ‚น0.18 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น48.38 B 68.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น246.46 B 758.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.494 T 19,046.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.226 T 4,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น45.62 B 58.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.68 B-90.65%๐Ÿ‡บ๐Ÿ‡ธ USA